Facebook
Twitter
LinkedIn
Forward
APP Cancer Research Summit 2025
Overview
The APP Cancer Research Summit (ACRS) is a two-day conference designed to empower advanced practice providers (APPs) with the knowledge and skills needed to excel in oncology-focused clinical research. ACRS will address various topics, including the basics of clinical trial design, toxicity grading, management, and documentation, the latest trends in cancer research, and more. This conference is planned and developed with clinical research APPs to ensure we provide the education and training APPs need and want. Held in conjunction with Summit for Novel Therapeutics in Oncology & Precision Medicine in Cancer (STOP Cancer), ACRS welcomes seasoned clinical research APPs and those interested in cancer research. Our goal is to provide a forum for APPs interested or practicing in cancer research to learn, network, and collaborate.
Designation | Advance (Ends August 26, 2025 at 11:59 p.m. Pacific time) | Standard (Begins August 27, 2025 at 12:00 a.m. Pacific time) |
| MD, DO, PhD | $490 | $590 |
Allied Health (NP, PA, RN, PharmD, Fellows, Residents, Retired) | $275 | $375 |
| Industry** | $790 | $890 |
**Defined as anyone employed by a drug, device, or diagnostic company. We allow Industry Professionals to register for our conferences unless you are employed in a sales role with your company. Please note that we will accept a limited number of Industry Professionals (excluding sales) to each conference.
Refunds of 50% of the registration fee will be provided if you cancel up to 30 days before the APP Cancer Research Summit (ACRS) commences. There are no refunds for cancellations within the 30-day window of the start of the event. To request a refund, please email [email protected]
Privacy Statement: For online registration, we take precautions to protect your information. When you submit sensitive information via the website, your information is protected both online and offline. In order to use this website, a user must first complete the registration form. During registration, a user is required to give certain information (such as name, email, mailing address, and payment information). This information is confidential and will only be used to contact you regarding your registration.
Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.
All Times Listed are for the Pacific Standard Time Zone
Thursday, September 25, 2025 | |
| 11:00am | Pre-Conference Activity |
| 5:00pm | Pre-Conference Registration Opens |
| 6:00pm | Industry Sponsored Dinner |
Friday, September 26, 2025 | |
| 7:00am | Check-in and Breakfast in Exhibit Hall |
| 8:00am | Horizon CME App Overview and CE Housekeeping |
| 8:10am | Welcome, Introductions, & CE Housekeeping |
| 8:15am | (01) The Daniel D. Von Hoff Keynote Lecture » TBA |
| 9:15am | Break | Refreshments in Exhibit Hall |
| Block One: Clinical Trials 101 | |
| 9:40am | (02) Clinical Trials Basics » Lisa Kottschade APRN, MSN, CNP, FAPO - Nurse Practitioner, Melanoma/Cutaneous Oncology-Immunotherapy Toxicity Clinic Associate Professor of Oncology Oncology APP Research Lead Mayo Clinic |
| 10:05am | (03) Clinical Trial Designs » Erin Pierce, MSN, APRN, FNP-C - Nurse Practitioner, Associate Clinical Investigator HonorHealth Research Institute |
| 10:30am | (04) How to Be a Good Investigator » TBA |
| 10:50am | (05) Q+A Panel and Discussion: Block One » Faculty from Sessions 02-04 |
| 11:00am | Gather for Lunch |
| 11:10am | Lunch |
| 11:55am | Dessert - Refreshments in Exhibit Hall |
| Block Two: Targeted Drug Development and Biomarker Testing | |
| 12:10pm | (06) Drug Development Process for Targeted Agents » Erin Pierce, MSN, APRN, FNP-C - Nurse Practitioner, Associate Clinical Investigator HonorHealth Research Institute |
| 12:35pm | (07) Biomarkers in Solid Tumors » TBA |
| 1:00pm | (08) Biomarkers in Hematologic Malignancies » Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN - Nurse Practitioner Department of Hematology and Medical Oncology Cleveland Clinic |
| 1:25pm | (09) Q+A Panel and Discussion: Block Two » Faculty from Sessions 06-08 |
| 1:40pm | Message from the Cancer Charities |
| 1:55pm | Break - Trivia for Charity in the Exhibit Hall |
| Block Three / Four: The Evolving Role of Advanced Practice Providers in Clinical Trials | |
| 2:15pm | (10) From Being a Sub-investigator to Clinical Trial Leadership » Gayle Jameson, MSN, ACNP-BC, AOCN - Nurse Practitioner, Associate Clinical Investigator HonorHealth Research Institute |
| 2:40pm | (11) Involvement in Clinical Trial Protocol Development/Writing/Review and Obtaining Funding » TBA |
| 3:05pm | (12) Working with a Biostatistician When Developing Your Own Investigator-Initiated Trial » TBA |
| 3:30pm | (13) Getting a Trial Through Startup/Operationalizing a Trial » Donna D. Catamero, ANP-BC, OCN, CCRC - Associate Director, Myeloma Research Adjunct Faculty, Mount Sinai Phillips School of Nursing The Mount Sinai Health System |
| 3:55pm | (14) How to Interpret Research Data and Develop a Conference Presentation/Publication » Carol Peyton Bryant, DNP, RN, ACNP, CCRN - Advanced Practice Provider Supervisor Hematology/Medical Oncology Division Co-Associate Chair for NP PAs Department of Medicine Instructor in Medicine Mayo College of Medicine and Science |
| 4:20pm | (15) Q+A Panel and Discussion: Block Three/Four » Faculty from Sessions 10-14 |
| 5:15pm | Networking Reception - Exhibit Hall |
Saturday, September 27, 2025 | |
| 7:00am | Check-in |
| 7:10am | Breakfast Symposium- sponsored by TBA » TBA |
| 7:55am | Horizon CME App Overview and CE Housekeeping |
| 8:00am | Welcome and Introductions |
| Block Five: Adverse Event Management in the Setting of a Clinical Trial | |
| 8:10am | (16) AEs with Targeted Agents » TBA |
| 8:40am | (17) AEs with Immune Checkpoint Inhibitors » Diane Barber, PhD, ANP-BC, AOCNP, FAANP, FAAN - Manager of Advanced Practice Providers Department of Investigational Cancer Therapeutics MD Anderson |
| 9:10am | (18) AE Grading & Documentation » Madeline Merrill, AGNP-BC, MSN - Clinical Trials Nurse Practitioner Memorial Sloan Kettering Cancer Center |
| 9:40am | (19) Q+A Panel and Discussion: Block Five » Faculty from Sessions 16-18 |
| 9:50am | Break - Refreshments in the Exhibit Hall |
| 10:20am | Poster Session |
| Block Six: Clinical Trial Methodology | |
| 10:55am | (20) Strategies for Patient Recruitment » Kelly Bolton, MD, PhD - Assistant Professor Washington University |
| 11:15am | (21) Novel Endpoints for Therapeutic Response in Early Phase Trials » Jordi Rodon Ahnert, MD, PhD - Associate Professor, Investigational Cancer Therapeutics Division of Cancer Medicine The University of Texas MD Anderson Cancer Center |
| 11:35am | (22) The Evolution of Agnostic Drug Approval: Where Are We Now? » TBA |
| 11:55am | (23) Role of Patient Advocacy in Early Phase Trials » TBA |
| 12:15pm | (24) Q+A Panel and Discussion: Block Six » Faculty from Sessions 20-23 |
| 12:35pm | Gather for Lunch |
| 12:45pm |
Buffet Lunch & Non-CME/CE Presentation Sponsored by TBA » TBA |
| 1:30pm | Dessert Break in Exhibit Hall |
| Block Seven: Advances With Bispecific Therapy and CAR-T Therapy in Cancer Care | |
| 1:45pm | (25) Recent Updates in MM » Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN - Nurse Practitioner Department of Hematology and Medical Oncology Cleveland Clinic |
| 2:10pm | (26) Advances in Bispecific Therapy and CAR-T Therapy in Hematologic Malignancies » Laura J. Zitella, MS, RN, ACNP-BC, AOCN - Associate Clinical Professor, Hematology Nurse Practitioner University of California, San Francisco |
| 2:35pm | (27) Advances in Bispecific Therapy and CAR-T Therapy in Solid Tumors » TBA |
| 3:00pm | Break - Refreshments in the Exhibit Hall |
| 3:20pm | (28) AEs with Bispecific Therapy and CAR-T Therapy in Hematologic Malignancies and Solid Tumors » TBA |
| 3:45pm | (29) Community Coordination of Care in Bispecifics » Charise Gleason, MSN, NP-BC, AOCNP - Corporate Director of Advanced Practice Providers Emory Healthcare Nurse Practitioner Bone Marrow and Stem Cell Transplant Center Winship Cancer Institute of Emory University |
| 4:10pm | (30) Q+A Panel and Discussion: Block Seven » Faculty from Sessions 25-29 |
| 4:30pm | Closing Comments |
We want to ensure that your time at the APP Cancer Research Summit (ACRS) 2025 conference is convenient and memorable. Staying at our host hotel provides a hassle-free experience and puts you at the heart of the activity surrounding the conference.
Overnight Accommodations:
Booking Deadline: TBA
Click here to book your room today!
Room rate: TBA
Parking: $45 Overnight Parking, Daily $25
Disclaimer:
All reservations must be booked using the link above before the closing date listed. Overnight accommodation, parking, and resort fees will revert back to standard hotel pricing outside of the dates above. A set number of rooms have been blocked off for the discounted pricing. If all of those rooms have already been booked, discounted pricing may not be available for additional rooms or accommodations.
Available Credit
- 9.75 ACPE PharmacyThe Washington State Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This conference is approved for up to 9.75 credit by the Washington State Pharmacy Association.
This activity is approved for up to 9.75 credit by the Washington State Pharmacy Association. ACPE#: 0130-9999-21--L01-P | Activity Type: Live| Start/End date: Thu, 09/25/2025 - 8:30am-Sat, 09/27/2025 - 4:10pm The Washington State Pharmacy Association (WSPA) is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education. NOTE FOR PHARMACISTS: It is the responsibility of the pharmacist or pharmacy technician to provide the correct information [NABP eProfile ID and DOB (in MMDD format)] within the evaluation, in order to receive credit for participating in this CPE activity. Following the activity’s end date, there is a maximum of 60 days allowed to upload the CPE information to the CPE Monitor. WSPA will upload the CPE information to the CPE monitor 50 days after the activity - please check your CPE Monitor at this time to ensure the CPE is uploaded in your profile. If you encounter any CPE problems, please contact WSPA at 425- 228-7171 - 9.75 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.
Horizon CME designates this Live activity for a maximum of 9.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 9.75 ANCCThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 9.75 credit.
- 1.50 PharmacologyThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 1.50 credit.